In 2018, understanding the number of flu deaths required looking at official surveillance reports, excess mortality studies, and age-specific impact. This overview compiles the most frequently referenced estimates and contextual factors for that season.
Public health authorities and researchers used death certificate data, pneumonia and influenza mortality thresholds, and statistical models to estimate both directly attributed flu deaths and excess deaths during the 2018 respiratory virus circulation period.
| Region | Reported Laboratory-Confirmed Flu Deaths | Estimated Excess All-Cause Deaths | Primary Data Source |
|---|---|---|---|
| United States | 18,000 reported deaths | 56,000 excess deaths | CDC preliminary estimates |
| European Union | 14,500 reported deaths | 21,000 excess deaths | ECDC and national agencies |
| World (global estimate) | N/A, fragmented reporting | 291,000–646,000 respiratory deaths | WHO modeling |
| Age Group Highlight | Higher share in adults 65+ | Substantial burden in working-age adults | Age- and sex-stratified analyses |
Mortality Surveillance And Data Sources For 2018
Health agencies relied on multiple systems to count flu deaths, including pneumonia and influenza mortality flags on death certificates, laboratory-confirmed counts, and excess mortality models that compared observed deaths to expected seasonal baselines.
In the United States, the CDC used provisional mortality data, ICD-10 coding thresholds, and statistical adjustments to address delays and undercounting, producing the first comprehensive 2018 season estimates in the interim reports.
In Europe, member states coordinated through the ECDC with varying notification practices and case definitions, which required careful harmonization when estimating population-level impact across the EU.
Globally, WHO applied a Bayesian regression framework to synthesize mortality data from surveillance sites, incorporating trends from previous seasons and factors such as circulation intensity and vaccine effectiveness.
Who Was Most Affected By The 2018 Flu Season
Older Adults And Chronic Conditions
Adults aged 65 years and older experienced the highest laboratory-confirmed and excess mortality rates, driven by both direct flu complications and exacerbations of cardiovascular and respiratory conditions.
Working-Age Adults In Certain Regions
Excess mortality analyses indicated that a substantial share of deaths occurred in younger and middle-aged adults, especially in areas with high infection rates and limited prior immunity.
Challenges In Estimating Flu Deaths In 2018
Estimation faced challenges such as timing of data reporting, variation in testing practices, and the influence of co-circulating respiratory viruses, which affected both attribution and case ascertainment.
Underlying health conditions and indirect effects, including disruptions to care-seeking and healthcare access during peak circulation, further complicated the interpretation of raw death counts.
Different methodologies, such as death certificate-based counts versus statistical excess models, sometimes produced widely different point estimates, highlighting the importance of interpreting ranges rather than single numbers.
Timeliness conflicted with accuracy, as initial public communications needed to balance awareness with the uncertainty inherent in early-season data.
Public Health Response And Communication In 2018
Authorities updated guidance on vaccination, antiviral use, and risk communication as new evidence emerged, emphasizing that substantial mortality could occur even in seasons with moderate severity indicators.
Targeted outreach to high-risk groups and improvements in vaccine uptake among healthcare workers were central to reducing avoidable deaths and easing strain on hospital systems.
Key Takeaways On The 2018 Flu Mortality Picture
- Reported laboratory-confirmed flu deaths were substantially lower than excess all-cause deaths, reflecting the indirect and unmeasured burden.
- Older adults faced the highest risk of severe outcomes, but excess deaths were also notable in younger age groups in several countries.
- Methodological choices, including modeling assumptions and data sources, led to a range of credible estimates rather than a single definitive count.
- Timely public communication and targeted vaccination efforts were central to reducing mortality and managing public expectations during and after the season.
- Ongoing improvements in surveillance, real-time excess mortality monitoring, and vaccination coverage remain priorities for future flu seasons.
FAQ
Reader questions
How many flu deaths did CDC estimate for the 2018 season in the United States?
The CDC estimated about 56,000 excess deaths and 18,000 laboratory-confirmed influenza-associated deaths for the 2018 season in the United States.
Why do reported flu deaths vary so widely across sources?
Reported flu deaths vary because different agencies use distinct methodologies, including laboratory confirmation requirements, death certificate classifications, and excess mortality modeling approaches.
Did the 2018 flu season have a notable impact on working-age adults?
Yes, excess mortality studies indicated that the 2018 season placed a significant burden on working-age adults, not only older populations, in many regions.
How do influenza death estimates change over time as data are revised?
Estimates are updated as additional death certificates are processed, testing results are finalized, and modeling methods are refined, which can shift the final numbers months after the season ends.